Becher Harald, Helfen Andreas, Michels Guido, Gaibazzi Nicola, Senior Roxy, Dietrich Christoph Frank
Mazankowski Alberta Heart Institute, Edmonton, AB T6G 2B7, Canada.
St. Marien Hospital, 44534 Lünen, Germany.
Diagnostics (Basel). 2025 Sep 18;15(18):2371. doi: 10.3390/diagnostics15182371.
Ultrasound enhancing agents (UEAs, formerly called contrast agents) have enhanced echocardiographic diagnostics of myocardial disease and masses as well as myocardial perfusion abnormalities. This review provides up-to-date guidance on the procedures and interpretations according to current recommendations of imaging societies and considering the results of recent major studies. For the different indications, a standardized approach has been created including technical aspects, pre-assessment and primary scan planes, contrast-enhanced ultrasound (CEUS) procedure, interpretation and reporting. In a previous publication (part 1) the UEAs, imaging methods, preparation of the patients and assessment of global and regional LV function with UEAs were included. The two parts represent a comprehensive state-of-the-art compendium on how to perform CEUS examinations in clinical echocardiography and provide advice on education, qualification and quality control.
超声增强剂（UEAs，以前称为造影剂）已改善了对心肌病、肿块以及心肌灌注异常的超声心动图诊断。本综述根据影像学会的当前建议并考虑近期主要研究结果，提供了有关程序和解读的最新指南。针对不同适应证，已制定了标准化方法，包括技术方面、预评估和主要扫描平面、对比增强超声（CEUS）程序、解读和报告。在之前的一篇出版物（第1部分）中，介绍了超声增强剂、成像方法、患者准备以及使用超声增强剂评估左心室整体和局部功能。这两部分代表了一份关于如何在临床超声心动图中进行对比增强超声检查的全面的最新纲要，并就教育、资质和质量控制提供了建议。
